Welcome to Trendlines
We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >
Subscribe to Our Newsletter
Stay in Touch
Editor’s note: In conjunction with the Trendlines Medical Asia Road Show, Trendlines was featured in the Singaporean and Chinese media.
By Benny Tan, TheEdge Singapore (11 July 2016)
David Todd Dollinger, co-chairman and co-CEO of The Trendlines Group, is constantly looking for ways to raise its profile, especially among potential investors and partners who may want to develop relationships with its investee companies. The bigger the following of its investee companies, the more likely shares in Trendlines will perform. See TheEdge Singapore article.
The article describes the portfolio companies “not having boundaries” when it comes to raising capital and the opportunities for companies to increase their exposure, reputation, and access on an international level. It also relates to —
Read the full article in Zaobao (Chinese PDF).
By Leong Chan Teik, NextInsight (5 July 2016)
HUNDREDS OF INVESTORS in Singapore yesterday got their first exposure to the entrepreneurial and innovative traits of start-ups of Israel, which has more high-tech start-ups and a larger venture capital industry than any other country in the world.
Trendlines Group brought seven of its Israel-based portfolio companies (out of 48) on a roadshow in Singapore, the first since Trendlines was listed on the Singapore Exchange last November.
The seven CEOs presented their innovative medical technologies in the morning to investors at Ocean Financial Centre and in the afternoon at SGX Centre. Read the full article on NextInsight.
By Chia Yan Min, Economics Correspondent, The Straits Times (5 July 2016)
Catalist-listed Israeli medical and agricultural investment company Trendlines Group will set up a medical technology incubator in Singapore this year and is screening for potential investments.
This is in line with its efforts to take advantage of growth opportunities in Singapore and the wider Asia-Pacific region, said chairman and chief executive officer Todd Dollinger at a briefing yesterday.
It was part of the firm’s roadshow showcasing seven of the medical technology companies in its portfolio – the first time it has held such an event here.
The company is looking to partner with both industry and government agencies here to support the activities of its new incubator, called Trendlines Medical Singapore.
The incubator will focus on “specific areas of interest for the partners we’re working with” as well as “producing and inventing products that have a special interest for Asia-Pacific”, said Mr Dollinger. Read the full article on The Straits Times.
By Aqil Luqman Nurhakim, The Business Times (5 July 2016)
THE Trendlines Group, an agritech and medtech incubator, kicked off its first Asian roadshow on Monday. Held at the Singapore Exchange (SGX) building, it showcases seven of the group’s Israel-based medical portfolio companies. See the full Business Times article (PDF).
By By Shiwen Yep, DealStreetAsia (4 July 2016)
In an interview with DEALSTREETASIA, Todd Dollinger, joint chief executive and co-chairman of the Israeli Trendlines Group, shares his insights into agricultural technology, discussing its history and what led it to list in Singapore. Read the full interview on DealStreet Asia.